Mark Lambrecht
@mlambrecht.bsky.social
#AI #datascience insights for patients, biopharma, agtech, hospitals and governments @SASSoftware
| PhD Bioscience Eng. cell & gene #kuleuven | #badminton
| PhD Bioscience Eng. cell & gene #kuleuven | #badminton
The structural collapse: how Google’s integrated stack is dismantling the OpenAI thesis open.substack.com/pub/shanakaa...
The Structural Collapse: How Google’s Integrated Stack Is Dismantling the OpenAI Thesis
A leaked internal memo reveals the tectonic shift reshaping artificial intelligence, where platform economics are defeating venture-backed innovation at the exact moment markets assumed the opposite.
open.substack.com
December 7, 2025 at 2:08 PM
The structural collapse: how Google’s integrated stack is dismantling the OpenAI thesis open.substack.com/pub/shanakaa...
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform www.drugdiscoverytrends.com/sas-launches...
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
SAS has released new clinical trial analytics software built on its Viya platform, offering cloud based tools for managing data, analysis and regulatory submissions.
www.drugdiscoverytrends.com
November 19, 2025 at 10:24 PM
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform www.drugdiscoverytrends.com/sas-launches...
Quantum computing is getting real—and Britain wants to lead www.economist.com/britain/2025...
Quantum computing is getting real—and Britain wants to lead
A long-elusive technology could give Britain an edge
www.economist.com
November 17, 2025 at 10:17 AM
Quantum computing is getting real—and Britain wants to lead www.economist.com/britain/2025...
on.ft.com/42EtHNk Novo Nordisk’s ‘lottery ticket’: can obesity drugs help treat Alzheimer’s?
Novo Nordisk’s ‘lottery ticket’: can obesity drugs help treat Alzheimer’s?
Results are due soon from two studies using semaglutide to treat thousands of people with the disease
on.ft.com
October 14, 2025 at 7:16 AM
on.ft.com/42EtHNk Novo Nordisk’s ‘lottery ticket’: can obesity drugs help treat Alzheimer’s?
A new AI model can forecast a person’s risk of diseases across their life
economist.com/science-and-...
from The Economist
economist.com/science-and-...
from The Economist
A new AI model can forecast a person’s risk of diseases across their life
Delphi-2M can predict which of more than 1,000 conditions a person might face next
economist.com
September 17, 2025 at 10:29 PM
A new AI model can forecast a person’s risk of diseases across their life
economist.com/science-and-...
from The Economist
economist.com/science-and-...
from The Economist
Europe is not pulling its weight in paying for drug development, says Tomas Philipson
economist.com/by-invitatio...
from The Economist
economist.com/by-invitatio...
from The Economist
Europe is not pulling its weight in paying for drug development, says Tomas Philipson
The former chair of America’s Council of Economic Advisers wants NATO-style spending targets for innovative medicines
economist.com
September 16, 2025 at 9:31 PM
Europe is not pulling its weight in paying for drug development, says Tomas Philipson
economist.com/by-invitatio...
from The Economist
economist.com/by-invitatio...
from The Economist
AI-powered brain device allows paralysed man to control robotic arm www.nature.com/articles/d41...
AI-powered brain device allows paralysed man to control robotic arm
The human user and AI have shared autonomy and constantly interact to complete tasks.
www.nature.com
September 2, 2025 at 7:07 PM
AI-powered brain device allows paralysed man to control robotic arm www.nature.com/articles/d41...
Tired of AI newsletters that just regurgitate press releases? substack.com/@paoloap/not...
Paolo Perrone (@paoloap)
Tired of AI newsletters that just regurgitate press releases?
Here's who actually ships knowledge:
🔬 Research (Without the PhD Flex)
→ Ahead of AI - @Sebastian Raschka, PhD
Explains papers smart ...
substack.com
August 24, 2025 at 10:51 AM
Tired of AI newsletters that just regurgitate press releases? substack.com/@paoloap/not...
How do we know mRNA vaccines are safe and effective? An explainer www.statnews.com/2025/05/21/m... via @statnews.com
How do we know mRNA vaccines are safe and effective? An explainer
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they are safe and effective.
www.statnews.com
August 7, 2025 at 10:55 PM
How do we know mRNA vaccines are safe and effective? An explainer www.statnews.com/2025/05/21/m... via @statnews.com
An mRNA Crime | Science | AAAS www.science.org/content/blog...
An mRNA Crime
www.science.org
August 7, 2025 at 12:18 PM
An mRNA Crime | Science | AAAS www.science.org/content/blog...
Using mRNA, scientists overcome a key challenge to HIV vaccines www.statnews.com/2025/07/30/m... via @statnews.com
Using mRNA, scientists overcome a key challenge to HIV vaccines
Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys
www.statnews.com
July 30, 2025 at 6:17 PM
Using mRNA, scientists overcome a key challenge to HIV vaccines www.statnews.com/2025/07/30/m... via @statnews.com
Good!
The European Union on Friday said it will stick to its timeline for implementing its landmark AI legislation, in response to a concerted effort by more than a hundred tech companies to delay the bloc’s AI rules.
techcrunch.com/2025/07/04/e...
The European Union on Friday said it will stick to its timeline for implementing its landmark AI legislation, in response to a concerted effort by more than a hundred tech companies to delay the bloc’s AI rules.
techcrunch.com/2025/07/04/e...
EU says it will continue rolling out AI legislation on schedule | TechCrunch
The European Union said it will stick to its timeline for rolling out its AI legislation, ignoring calls by tech companies to delay the bloc's AI rules.
techcrunch.com
July 4, 2025 at 5:57 PM
Good!
The European Union on Friday said it will stick to its timeline for implementing its landmark AI legislation, in response to a concerted effort by more than a hundred tech companies to delay the bloc’s AI rules.
techcrunch.com/2025/07/04/e...
The European Union on Friday said it will stick to its timeline for implementing its landmark AI legislation, in response to a concerted effort by more than a hundred tech companies to delay the bloc’s AI rules.
techcrunch.com/2025/07/04/e...
The Alzheimer’s drug pipeline is healthier than you might think
economist.com/science-and-...
from The Economist
economist.com/science-and-...
from The Economist
The Alzheimer’s drug pipeline is healthier than you might think
It reflects a more nuanced understanding of the disease
economist.com
June 3, 2025 at 6:14 PM
The Alzheimer’s drug pipeline is healthier than you might think
economist.com/science-and-...
from The Economist
economist.com/science-and-...
from The Economist
Making Europe more attractive for conducting clinical trials | www.ihi.europa.eu/news-events/...
Making Europe more attractive for conducting clinical trials
IHI and IMI projects are enhancing the environment in Europe for conducting clinical trials by connecting relevant sites and experts, investigating new trial designs and protocols, and developing tool...
www.ihi.europa.eu
May 26, 2025 at 12:10 PM
Making Europe more attractive for conducting clinical trials | www.ihi.europa.eu/news-events/...
Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA www.statnews.com/2025/05/06/v...
Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA
Vinay Prasad, tapped to be a top official at the FDA, has never shied from speaking his mind.
www.statnews.com
May 10, 2025 at 5:41 PM
Vinay Prasad, in his own words, outlines the philosophy he’ll bring to the FDA www.statnews.com/2025/05/06/v...
Can AI solve the clinical data problem? www.science.org/content/blog...
Can AI solve the clinical data problem?
www.science.org
April 29, 2025 at 10:37 PM
Can AI solve the clinical data problem? www.science.org/content/blog...
AstraZeneca rejoins PhRMA, two years after leaving lobby group endpts.com/astrazeneca-...
AstraZeneca rejoins PhRMA, two years after leaving lobby group
British drugmaker AstraZeneca is rejoining the drug industry's major US lobbying group, PhRMA, roughly two years after quitting the organization.
endpts.com
April 23, 2025 at 12:21 PM
AstraZeneca rejoins PhRMA, two years after leaving lobby group endpts.com/astrazeneca-...
How AI is reshaping wildlife conservation — for better or worse
Efforts to “save species” with deep learning are not without controversy. www.theverge.com/ai-artificia...
Efforts to “save species” with deep learning are not without controversy. www.theverge.com/ai-artificia...
AI is reshaping wildlife conservation as we know it
Efforts to “save species” with deep learning are changing conservation, for better or worse.
www.theverge.com
April 22, 2025 at 7:37 PM
How AI is reshaping wildlife conservation — for better or worse
Efforts to “save species” with deep learning are not without controversy. www.theverge.com/ai-artificia...
Efforts to “save species” with deep learning are not without controversy. www.theverge.com/ai-artificia...
Reposted by Mark Lambrecht
Two key management moves at Galapagos:
- CEO Paul Stoffels (ex-JNJ CSO) is retiring this year, but will remain chairman
- Ex-Neumora CEO Henry Gosebruch will be CEO of the planned GLPG spinout
Release: www.globenewswire.com/news-release...
Background ($): www.biocentury.com/article/6546...
- CEO Paul Stoffels (ex-JNJ CSO) is retiring this year, but will remain chairman
- Ex-Neumora CEO Henry Gosebruch will be CEO of the planned GLPG spinout
Release: www.globenewswire.com/news-release...
Background ($): www.biocentury.com/article/6546...
Makeover for Gilead-Galapagos deal to yield newco primed for BD
What has become of Galapagos a little more than five years after its major partnership with Gilead is far from what the partners had envisioned for the meg...
www.biocentury.com
April 21, 2025 at 9:26 PM
Two key management moves at Galapagos:
- CEO Paul Stoffels (ex-JNJ CSO) is retiring this year, but will remain chairman
- Ex-Neumora CEO Henry Gosebruch will be CEO of the planned GLPG spinout
Release: www.globenewswire.com/news-release...
Background ($): www.biocentury.com/article/6546...
- CEO Paul Stoffels (ex-JNJ CSO) is retiring this year, but will remain chairman
- Ex-Neumora CEO Henry Gosebruch will be CEO of the planned GLPG spinout
Release: www.globenewswire.com/news-release...
Background ($): www.biocentury.com/article/6546...
Law professors side with authors battling Meta in AI copyright case techcrunch.com/2025/04/11/l...
Law professors side with authors battling Meta in AI copyright case | TechCrunch
A group of professors specializing in copyright law has filed an amicus brief in support of authors suing Meta for allegedly training models without permission.
techcrunch.com
April 11, 2025 at 9:37 PM
Law professors side with authors battling Meta in AI copyright case techcrunch.com/2025/04/11/l...
AI models are helping dirty industries go green www.economist.com/science-and-...
AI models are helping dirty industries go green
Mining companies and steelmakers are feeling the benefits
www.economist.com
April 11, 2025 at 8:37 PM
AI models are helping dirty industries go green www.economist.com/science-and-...